CRISPR Therapeutics AG (NASDAQ:CRSP)
| 83.59 Delayed Data As of Sep 30 |  -1.35 / -1.59%Today’s Change | 32.30 Today|||52-Week Range 105.12 | +37.25% Year-to-Date |
Latest CRSP News | Press Releases
| Better Buy: CRISPR Therapeutics vs. Editas Medicine Sep 30 / MotleyFool.com - Paid Partner Content | Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis Therapy Sep 17 / MotleyFool.com - Paid Partner Content |
| 3 Stocks That Could Double Your Money Sep 24 / MotleyFool.com - Paid Partner Content | CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow Sep 11 / Seeking Alpha - Paid Partner Content |
| CRISPR Therapeutics Gene Therapy CTX001 Gets PRIME Status Sep 23 / Zacks.com - Paid Partner Content | Editas Medicine up 5% on favorable CRISPR/Cas9 patent ruling Sep 11 / Seeking Alpha - Paid Partner Content |
| Crispr: The Frontier Of Gene Editing Sep 18 / Seeking Alpha - Paid Partner Content |
